SBP solbec pharmaceuticals limited

letter to shareholders, page-3

  1. 5,995 Posts.
    lightbulb Created with Sketch. 162
    re: $$$ letter to shareholders Well hello Arthur . dont know anything about horses pricks , but if they can also cure it in horses asses you should be OK . Will let you know when the trials start .
    I would be interested to hear anything you know about those Mesothelioma trials , science , mode of action , company name etc.
    As for skin cancer , there is a glossy photo in the glossy handout of a 6cm bulging skin cancer before and another after one injection where it is totally collapsed . So yes it still works on skin cancer .
    Also in the glossy handout is a picture of the way it clears up psorisis in a very diluted form of the drug . It took 28 days , but you are sure to know that is how long it takes for the good skin to grow through .
    The glossy handout also quotes SBP002s response rate over 68 different tumours as tested by Dr Robert Nagourney of an average of 57% . examples , breast 59% , ovarian 52% , gastric 66% , NSCLC(lung) 75% . Response rates mean at least 75% reduction of tumor and does not include disease stabilization .
    You have to remember all the above response rates were achieved on human tumors ex-vivo . It does not take into account the immune system boost that seems to take place as the 002 attacks the tumor .
    The brocure also talks about SBPs ability to modulate the cytokine IL-6 . It is known to make people feel unwell and is involved in cancer cell proliferation .
    This would make it an ideal candidate to use with other known chemo treatments .
    It also opens up use on a wide range of IL-6 related diseases such as rheumatoid arthritis , psoraisis , psoraisitic arthritis , and there are too many more for me to type all the way to cardio myopathy . Patents are lodged for these applications .
    The brocure also details tests made so far to use the binding effect to cancer cells a a diagnostic tool where a visualising agent was added to the drug to successfully identify cancer cells .
    As there will be about 15000 biotech professionals at the conference and only 3 days , I would think the brocure is good value .
    Dont forget the info on the meso trials Arthur . Looking forward to it .
    Skint .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.